when was semaglutide patented Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India Brazilian federal court denies semaglutide

Physiology, Appetite And Weight Regulation

GLP-1 Shots is a weekly injection that has been clinically proven to help people lose weight safely and effectively

95% CI: 0.920.98

The Courts have concluded that these injuries are widespread and common enough to warrant a new lawsuit for those who have suffered from eye injuries that have no known cure or treatment

Dec 29, 2025 CagriSema represents the next evolution in medical weight loss - Novo Nordisk's branded combination of semaglutide 2.4mg and cagrilintide 2.4mg that produced 15-25% body weight loss in Phase 3 trials

Most patients start eating smaller portions or feeling satisfied longer between meals